Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omacor in Chinese patients with hypertriglyceridemia
CTR20160569Phase 3Completed
- Sponsor
- Pronova BioPharma
- Start
- Sep 2016
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of omega-3-acid triglycerides in hypertriglyceridemia, endogenous hypertriglyceridemia, Familial Combined Hyperlipidemia (FCH), dysbetalipoproteinemia (DBL), sponsored by Pronova BioPharma. Started Sep 2016; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
hypertriglyceridemiaendogenous hypertriglyceridemiaFamilial Combined Hyperlipidemia (FCH)dysbetalipoproteinemia (DBL)
Beyond the preview
Go deeper on CTR20160569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160569.